🇺🇸 FDA
Patent

US 7485296

PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer

granted A61KA61K2039/505A61K31/704

Quick answer

US patent 7485296 (PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer) held by The Regents of the University of California expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K31/704, A61K38/00, A61K39/395